zadnja posodobitev :
19/11/2024
Antibiotik   Ertapenem  
Brizgalka
Stabilnost raztopine Stabilnost mešanice Faktorji, ki vplivajo na stabilnost Kompatibilnost način aplikacije Viri pdf
   Kemična formula  

Lastniško ime   Lastniško ime     

Sestava pomožnih snovi je med paralelami lahko različna

Ertacrit Indija
Ertagram Peru
Ertamac Indija
Invanz Argentina, Avstralija, Avstrija, Brazilija, Čile, Danska, Egipt, Ekvador, Finska, Francija, Grčija, Irska, Islandija, Italija, Japonska, Kanada, Kolumbija, Luksemburg, Madžarska, Malezija, Maroko, Mehika, Nemčija, Nizozemska, Norveška, nova Zelandija, Peru, Poljska, Portugalska, Romunija, Španija, Švedska, Švica, Turčija, Velika Britanija, Venezuela, Združene države Amerike, Združeni arabski emirati
Lyortam Čile, Peru
Viri   Brizgalka   Viri : Ertapenem  
Tip objava
1906 časopis McQuade MS, Van Nostrand V, Shariter J, Kanike JD, Forsyth RJ.
Stability and compatibility of reconstituted ertapenem with commonly used iv infusion and coinfusion solutions.
Am J Health-Syst Pharm 2004 ; 61: 38-45.
1912 Traduction Laboratorij Ertapenem (Invanz®) - Summary of Product Characteristics
Merck Sharp Dohme 2016
1982 časopis Trissel LA, Ogundele AB.
Compatibility of anidulafungin with other drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2005 ; 62: 834-837.
2178 časopis Zajac M, Cielecka-Piontek J, Jelinska A.
Stability of ertapenem in aqueous solutions.
J Pharm Biomed Anal 2007 ; 43: 445-449.
2247 časopis Chan P, Heatherly K, Kupiec T.C, Trissel L.A.
Compatibility of caspofungin acetate injection with other drugs during simulated Y-site coadministration.
Int J Pharm Compound 2008 ; 12, 3: 276-278.
3208 časopis Phipps Stephen D, Peacock Gina F, Smith Douglas L .
Stability of Ertapenem in an Elastomeric Infusion Device.
Int J Pharm Compound 2011 ; 15, 3: 252-254.
3254 časopis Housman S.T, Tessier P.R, Nicolau D.P, Kuti J.L.
Physical compatibility of telavancin hydrochloride with select i.v. drugs during simulated Y-site administration
Am J Health-Syst Pharm 2011 ; 68: 2265-2270.
3549 Traduction Laboratorij Amikacine B Braun - Résumé des caractéristiques du produit.
B Braun 2012
3674 Traduction Laboratorij Erythromycin lactobionate - Summary of Product Characteristics
PanPharma 2016
3717 časopis Jain J.G, Sutherland C, Nicolau D.P, Kuti J.L.
Stability of ertapenem 100 mg/mL in polypropylene syringes stored at 25, 4, and -20 °C.
Am J Health-Syst Pharm 2014 ; 71:1480-1484
3824 časopis Boudi S, Roy H, Forest JM, Leclair G.
Compatibilité physique de l'association amoxicilline-acide clavulanique en injection avec plusieurs autres médicaments lors d'une administration en Y.
Pharmactuel 2023 2023;56,3:91-98
3827 poster Ghazi I.M, Hamada Y, Nicolau D.P.
Compatibility of tedizolid phosphate with selected intravenous drugs via simulated Y-site conditions.
ASHP Midyear 2015
3828 poster Thabit A.K, Hamada Y, Nicolau D.P.
Ceftozolane/tazobactam physical compatibility during simulated Y-site administration.
ASHP Midyear 2015
3829 poster So W, Kim L, Thabit A.K, Nicolau D.P, Kuti J.L.
Compatibility of isavunazonium sulfate during simulated Y-site administration.
ASHP Midyear 2015
3891 časopis Walker S.E, Law S, Perks W, Iazzetta J.
Stability of Ertapenem 100 mg/mL in Manufacturer’s Glass Vials or Syringes at 4°C and 23°C
Can J Hosp Pharm 2015 ; 68, 2: 121-126.
3997 časopis Katip W.
Visual compatibility of colistin injection with other antibiotics during simulated Y-site administration.
Am J Health-Syst Pharm 2017 ; 74:14 : 1099-1102
4055 časopis Monogue M, Almarzoky Abuhussain S, Kuti J, Nicolau D.
Physical compatibility of fosfomycin for injection with select i.v. drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2018 , 75, 1:36-44
4145 časopis Asempa T.E, Avery L.M, Kidd J.M, Kuti J.L, Nicolau D.P.
Physical compatibility of plazomicin with select i.v. drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2018 ;75,14:1048-1056
4319 časopis Lessard J-J, Caron E, Schérer H, Forest J-M, Leclair G.
Compatibility of Y-site Injection of Meropenem Trihydrate With 101 Other Injectable Drugs.
Hosp Pharm 2020 ; 55, 5: 332-337.
4528 časopis Lu J, Liu Q, Kupiec T, Vail H, Lunch L, Fam D, Vu N.
Physical Compatibility of Cefiderocol with Selected Intravenous Drugs During Simulated Y-site Administration.
Int J Pharm Compound 2021 ;25,1:52-61
4742 časopis Macoviciuc M, Nguyen C, Forest J-M, Leclair G.
Compatibilité physique de l’acétaminophène injectable avec 102 autres médicaments lors d’une administration en Y.
Pharmactuel 2022 ; 55, 4: 247-255.
4801 časopis Ruiz V, Yuwei Shen Y, Abouelhassan Y, Fouad A, Nicolau D, Kuti J.
Physical compatibility of sulbactam/durlobactam with select intravenous drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2024 ;51,1:

  Mentions Légales